Committee advances bill to create a uterine-fibroids advisory commission; adds Ochsner representative

The committee reported House Bill 525 with amendments after Representative Walters presented the bill and a technical amendment set. HB 525 would create a uterine-fibroids commission to evaluate existing groups focused on fibroids and related reproductive-health conditions, collaborate with stakeholders and provide advisory reports to the governor and the Louisiana Department of Health.

Representative Walters described the commission's goals in a prepared presentation. She said the commission would review functions of existing groups focused on uterine fibroids, polycystic ovary syndrome (PCOS) and endometriosis, engage stakeholders and require an annual report. The sponsor outlined common symptoms and health impacts associated with fibroids, PCOS and endometriosis, and said the commission would help centralize data and reporting that can guide policy.

Committee members considered a committee-originated amendment that increased commission membership from 12 to 13 by adding a representative from Ochsner Health; the amendment specifies that Ochsner will select its appointee. The amendment was adopted. Several advocacy organizations filed cards in support; the committee then voted to report HB 525 with the adopted amendment.

Next steps: HB 525 advances with an amendment that adds an Ochsner Health representative and a requirement for an annual report from the commission.